2020 symposia series 1 embracing new treatment options in
play

2020 Symposia Series 1 Embracing New Treatment Options in the - PowerPoint PPT Presentation

2020 Symposia Series 1 Embracing New Treatment Options in the Management of Migraine Headache Learning Objectives Apply current diagnostic criteria for differential diagnosis of migraine to increase early recognition and treatment Employ


  1. 2020 Symposia Series 1

  2. Embracing New Treatment Options in the Management of Migraine Headache

  3. Learning Objectives • Apply current diagnostic criteria for differential diagnosis of migraine to increase early recognition and treatment • Employ current migraine guideline recommendations and management strategies to establish improved patient treatment plans • Identify the appropriate use of established and emerging treatment options for migraine and related monitoring and safety options 3

  4. Migraine Is Common US Prevalence (%) 30 Female 25 Female Male Migraine Prevalence (%) Male 20 Sex 17 6 15 Race White 17 6 10 Black 14 4 5 Highest prevalence Age 30 to 39 years 24 7 0 0 20 30 40 50 60 70 80 100 Age (years) 4 Lipton RB, et al. Headache. 2001;41:646-657; Lipton RB, et al. Neurology . 2007;68:343-349.

  5. Migraine Is Debilitating • 2nd most disabling episodic Attendance at work 8 18 47 condition after lower back pain Family situation 4 23 38 • Migraine is a chronic disease Leisure time 8 14 37 with episodic manifestations Pursuing studies 8 12 27 7 8 28 Sexual life Social position 3 10 24 Very negative influence 3 6 22 Quite negative influence Love Some negative influence 4 20 Finances 6 Pursuing career 3 8 16 Finding friends 2 8 0 20 40 60 80 Percentage of Migraineurs (N = 423) Feigin VL et al. Lancet Neurol. 2019, 18:459-480; Institute for Health Metrics and Evaluation (IHME). Findings from the Global Burden of Disease 5 Study 2017. Seattle, WA: IHME, 2018; Linde M, et al. Cephalalgia. 2 004;24:455-465.

  6. Pathophysiology of Migraine — Implications for Management Pain perception Cortex • Cortical spreading depolarization, altered connectivity • Migraine aura and cognitive symptoms Hypothalamus • Target for neuromodulation • Activation in premonitory phase Thalamus • Premonitory symptoms • Sensitization of alteration of thalamocortical circuits • Target for hypothalamic • Sensory sensitivity and allodynia peptides and modulators • Target for neuromodulation Upper Cervical Nerves Trigeminocervical Complex • Pain transmission or • Pain transmission or sensitization sensitization • Headache and neck pain Throbbing • Neck and head pain • Target for medications and neuromodulation pain • Target for local injections and neuromodulation Release of CGRP • Multiple potential sources or sites of action • Headache and other symptoms • Target for small-molecule antagonists and antibodies 6 Charles A. Lancet Neurol. 2018;17:174-182.

  7. What Happens During a Migraine Attack? Clinical Phases of Migraine ~4 to 72 hours ≤1 hour Prodrome Headache Postdrome Aura (if present) • • • • Fatigue Localization Fatigue Visual • • • – Food craving Throbbing GI upset Scintillating • • • scotoma Muscle pain Nausea Cognitive • • • change Sensory Cognitive change Vomiting • • • • Muscle pain Motor Mood change Photophobia • • • Mood change Sensory disruption Phonophobia Adapted from: American Migraine Foundation. americanmigrainefoundation.org/understanding-migraine/timeline-migraine-attack/. 7 Accessed Apr 13, 2020.

  8. Case Study: Colleen, a 42-Year-Old Call Center Operator Presenting Complaint History • “Tension headaches” that have become • Minor headaches since she was in her teens more frequent and debilitating in the past • No history of trauma or unusual stresses 10 years • Bilateral tubal ligation • Current headaches not relieved by • Works from home most days nonprescription NSAIDs Physical Exam and Medications • Recurrent insomnia, occasional • Height: 5 ft 6 in; weight: 186 lb; BMI: 30.0 kg/m 2 constipation • Hypertension controlled with amlodipine 5 mg/d 8 NSAID = nonsteroidal anti-inflammatory drug.

  9. What to Ask About When Taking a Thorough Headache History • Frequency and patterns ‒ Any significant changes • Location • Duration • Quality and intensity • Time to peak intensity • Preceding symptoms (eg, how the headache begins; triggers) • Warning symptoms and aura • Associated symptoms and level of disability • Aggravating or relieving factors Weatherall MW. Ther Adv Chronic Dis. 2015;6:115-123. 9

  10. Case Study (cont’d): Colleen’s History • Unilateral pattern of pain, sometimes behind browbone • Headaches often worse around menses • Headaches 4 to 6 times a month for the last 2 years, lasting from a few hours to up to a day • Severity varies but is usually moderate or severe • Interfere with work and household needs about 1 or 2 days a week • Loud noises and bright lights make headaches worse; sometimes her neck becomes sore • Sometimes feels congested and has a runny nose • Headaches often accompanied by nausea • Neurologic exam within normal limits 10

  11. Typical Presentations of Common Forms of Headache TENSION TYPE MIGRAINE CLUSTER “SINUS” • Pain “like a band” • • Unilateral pain Pain in and around one • Pain behind browbone squeezing the head • eye Often with nausea and and/or cheekbones • • Primary headache visual changes Primary headache • Secondary headache per • per ICHD-3 per ICHD-3 Primary headache ICHD-3 per ICHD-3 • Unless clear signs of active infection, often is a migraine headache ICHD-3 = International Classification of Headache Disorders, 3rd edition. Cady RK, Schreiber CP. Otolaryngol Clin North Am . 2004;37:267-288; Headache Classification Committee of the International Headache Society (IHS). Cephalalgia. 2018;38:1-211; brgeneral.org www.brgeneral.org/healthy-lifestyle-blog/2018/november/4-major-types-of-headaches-and-where- they-hurt/. Accessed Apr 22, 2020. 11

  12. Typical Presentations of Common Forms of Headache TENSION TYPE MIGRAINE CLUSTER “SINUS” • Pain “like a band” • • Unilateral pain Pain in and around one • Pain behind browbone squeezing the head • eye Often with nausea and and/or cheekbones • • Primary headache visual changes Primary headache • Secondary headache per • per ICHD-3 per ICHD-3 Primary headache ICHD-3 per ICHD-3 • Unless clear signs of active infection, often is a migraine headache ICHD-3 = International Classification of Headache Disorders, 3rd edition. Cady RK, Schreiber CP. Otolaryngol Clin North Am . 2004;37:267-288; Headache Classification Committee of the International Headache Society (IHS). Cephalalgia. 2018;38:1-211; brgeneral.org www.brgeneral.org/healthy-lifestyle-blog/2018/november/4-major-types-of-headaches-and-where- they-hurt/. Accessed Apr 22, 2020. 12

  13. Migraine vs Tension-type Headache: A Common Misdiagnosis Migraine Tension-type ≥2 of the following ≥2 of the following • • Unilateral (59% of migraines) Bilateral • • Pulsating (85% of migraines) Not pulsating • • Moderate to severe intensity lasting between 4 and Mild to moderate intensity 72 hours • Not aggravated by routine physical activity • Aggravation by routine physical activity ≥1 of the following • No nausea/vomiting • • Nausea/vomiting (73% of migraines) One or neither: photophobia/phonophobia • Photophobia/phonophobia (~80% of migraines) Not attributable to another disorder Not attributable to another disorder Headache Classification Committee of the International Headache Society (IHS). Cephalalgia. 2018;38:1-211; Lipton RB, et al. Headache. 2001;41:646-657. 13

  14. Landmark Study: How Likely Is it That an Episodic Headache Is Migraine? • Prospective, open-label study of patients with episodic headache (N = 1203) Probable • >90% seen in primary care migraine Episodic tension-type • (n = 67) 18% Self-report or physician diagnosis of migraine (n = 11) 3% almost always correct Unclassifiable (n = 11) 3% • Self-report or physician diagnosis of Migraine nonmigraine almost always later found (n = 288) 76% out to be migraine Tepper SJ, et al. Headache. 2004;44:856-864. 14

  15. ID Migraine™: Simplified Diagnostic Criteria for Migraine Symptoms in the last 3 months: Light sensitivity with ❑ headache Nausea with headache ❑ Decreased ability to ❑ function with headache Any 2 of the 3 above symptoms = migraine Lipton RB, et al. Neurology. 2003;12:375-382. 15

  16. Red Flags: SNOOP S Systemic involvement (fever, myalgias, weight loss) Systemic disease (cancer, AIDS) N Neurologic symptoms or signs O Onset sudden (thunderclap headache) O Onset after age 50 years Pattern of change: progressive headache/fewer headache-free periods; change in P type of headache; headache associated with pregnancy; headache related to body position Be alert to signs/symptoms of secondary headache. Dodick DW. Adv Stud Med . 2003;3:87-92; Dodick DW. N Engl J Med. 2006;354:158-165. 16

  17. Headache Impact Test (HIT)-6 and Migraine Disability Assessment (MIDAS) Test HIT-6 • Measures the impact headaches have on job, school, home and social situations • Total score ≥50 suggests significant impact MIDAS • Measures how migraines affect everyday functioning Kosinski M, et al . Qual Life Res . 2003;12:963-974. 17

  18. Case Study (cont’d) • Clinical findings are consistent with migraine without aura • Colleen is surprised because she thought migraines were always associated with an aura • Says that she is “just happy to know what is going on” • Headaches have a significant impact on her daily activity 18

Recommend


More recommend